The Efficacy of Lidocaine in Disrupting Cocaine Cue-Induced Memory Reconsolidation.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 18 10 2019
revised: 06 04 2020
accepted: 04 05 2020
pubmed: 2 6 2020
medline: 2 3 2021
entrez: 2 6 2020
Statut: ppublish

Résumé

Cue-induced craving memories, linked to drug-seeking behaviors, require key molecular processes for memory reconsolidation. Lidocaine, a sodium channel blocker, inhibits NMDA receptor activation and suppresses nitric oxide and ERK production. These processes are required for memory re-consolidation; inhibiting them may reduce cue-related craving memories in cocaine dependent subjects. To assess the efficacy of lidocaine in decreasing cue-induced cocaine craving and cocaine use. Treatment-seeking cocaine-dependent participants (n = 33, 25 men) were recruited. Personalized craving and relaxation scripts were developed. Participants were then randomly assigned in a double-blind design to either receive intravenous lidocaine immediately following a cocaine craving script (lidocaine/craving), saline following a craving script (saline/craving), or lidocaine following a relaxation script (lidocaine/relax). One week following the infusion, cue-induced craving was assessed in the same paradigm without an infusion. Cocaine use and craving were assessed for 4 weeks following infusion. The administration of lidocaine during craving induction (lidocaine/craving) did not decrease cue-induced craving during craving reactivation one week later or craving and cocaine use over the 4-week follow-up period compared to the saline/craving group. There were no significant differences in craving and cocaine use between the lidocaine/relax and saline/craving groups. Lidocaine administered following craving induction did not decrease subsequent cue-induced craving or cocaine use. Blocking the reconsolidation of craving-related memories with pharmacological agents remains an important area of investigation.

Identifiants

pubmed: 32480252
pii: S0376-8716(20)30227-1
doi: 10.1016/j.drugalcdep.2020.108062
pii:
doi:

Substances chimiques

Voltage-Gated Sodium Channel Blockers 0
Lidocaine 98PI200987
Cocaine I5Y540LHVR

Banques de données

ClinicalTrials.gov
['NCT01929343']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108062

Subventions

Organisme : NIDA NIH HHS
ID : R21 DA043150
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000451
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001105
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Josh E Becker (JE)

Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX USA; School of Behavior and Brain Sciences, UT Dallas, Dallas, TX USA.

Julianne L Price (JL)

Department of Psychiatry, University of Florida, Gainesville, FL USA.

David Leonard (D)

David Leonard Statistical Consulting, Wichita Falls, TX USA.

Alina Suris (A)

Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX USA; VA North Texas Health Care System, Dallas, TX USA.

Enas Kandil (E)

Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO USA; Department of Anesthesiology & Pain Management, UT Southwestern Medical Center, Dallas, TX USA; School of Behavior and Brain Sciences, UT Dallas, Dallas, TX USA.

Meredith Shaw (M)

Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX USA; VA North Texas Health Care System, Dallas, TX USA.

Sven Kroener (S)

School of Behavior and Brain Sciences, UT Dallas, Dallas, TX USA.

E Sherwood Brown (ES)

Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX USA.

Bryon Adinoff (B)

Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH